Hjem › Brystkreft › Connecticut › Bridgeport
Kliniske studier for Brystkreft i Bridgeport, CT
21 studier for Brystkreft søker deltakere på steder i og rundt Bridgeport (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruttererFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mi unna
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruttererFase 3
- Research Site, Stony Brook · 18 mi unna
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruttererFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mi unna
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mi unna
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekrutterer
- Stony Brook Cancer Center, Stony Brook · 18 mi unna
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruttererFase 1/2
- Stony Brook University Hospital, Stony Brook · 18 mi unna
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruttererFase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruttererFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi unna
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruttererFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mi unna
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mi unna
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mi unna
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruttererFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi unna
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi unna
- og 1 flere
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruttererFase 2
- Stony Brook Cancer Center, Stony Brook · 18 mi unna
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruttererFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mi unna
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mi unna
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
RekruttererFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mi unna
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruttererFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mi unna
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruttererFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mi unna
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruttererFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mi unna
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mi unna
- Stony Brook University Medical Center, Stony Brook · 18 mi unna
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruttererObservasjonsstudie
- Stony Brook Medicine, Stony Brook · 18 mi unna
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
RekruttererTidlig fase 1
- Stony Brook Breast Center, Stony Brook · 18 mi unna
Definitive Radiation Therapy for Inoperable Breast Cancer
Rekrutterer
- Stony Brook University Cancer Center, Stony Brook · 18 mi unna
Definitive Radiation for High-Risk Spine Metastases
RekruttererFase 2
- Stony Brook University Hospital, Stony Brook · 18 mi unna
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruttererObservasjonsstudie
- Stony Brook University Cancer Center, Stony Brook · 18 mi unna
Brystkreft-studier i andre byer
- New York City, NY136 studier
- Houston, TX126 studier
- Boston, MA112 studier
- Nashville, TN81 studier
- Los Angeles, CA73 studier
- Edison, NJ68 studier
- St. Louis, MO64 studier
- Queens, NY64 studier
- Durham, NC64 studier
- Chicago, IL59 studier
- Philadelphia, PA56 studier
- Dallas, TX55 studier
Andre studier i Bridgeport
- Ikke-småcellet lungekreft14 studier
- Lungekreft13 studier
- Akut myelogen leukemi12 studier
- Kardiovaskulær sykdom9 studier
- Kreft (alle typer)8 studier
- Plateepitelcancer i hode og hals8 studier
- Metastatisk kreft7 studier
- Hjertesvikt7 studier
- Hjaneurisme6 studier
- Multipelt myelom6 studier
- Prostatakreft6 studier
- Eggstokkreft5 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.